Analysis of 16 cystic fibrosis mutations in Mexican patients
✍ Scribed by Villalobos-Torres, C.; Rojas-Martínez, A.; Villareal-Castellanos, E.; Cantú, J. M.; Sánchez-Anzaldo, F. J.; Saiki, R. K.; Barrera-Saldaña, H. A.
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 142 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
✦ Synopsis
We carried out molecular analysis of 80 chromosomes from 40 unrelated Mexican patients with a diagnosis of cystic fibrosis. The study was performed in two PCR steps: a preliminary one to identify mutation ⌬F508, the most frequent cause of cystic fibrosis worldwide, and the second a reverse dot-blot with allele-specific oligonucleotide probes to detect 15 additional common mutations in the Caucasian population. A frequency of 45% for ⌬F508 was found, making it the most common in our sample of Mexican patients. Another five mutations (G542X, 3849 + 10 kb C→T, N1303K, S549N, and 621 + 1 G→T) were detected, and these accounted for 11.25%. The remaining mutations (43.75%) were undetectable with the methodology used.
📜 SIMILAR VOLUMES
Mutation analysis was performed on 42 unrelated Israeli Arab CF patients. The previously known mutations in this population, ∆ ∆F508, N1303K, G542X, 4010delTATT, and S549R(T>G), were identified in 57 CF alleles, leaving 28 CF alleles with unknown mutations. Screening of the coding sequence of the CF
The suggested incidence of cystic fibrosis (CF) in Asian migrants (Indians and Pakistanis) in the United Kingdom is about 1 in 10,000 to 12,000 [Goodchild et al., 1974]. There are no large studies on CF in Asian Indians. The disorder is thought to be rare and most studies from the Asian subcontinent
The majority of patients with cystic fibrosis (CF) will grow into adulthood. Despite this improvement in survival, the disease is progressive, especially with respect to the decline in pulmonary function, which in turn may have an impact on a patient's quality of life. In this study we evaluated the
Asthma is a complex genetic disorder that affects 5% of adults and 10% of children worldwide. The complete characterization of the cystic fibrosis transmembrane conductance regulator (CFTR) gene identified missense mutations in 15% of 144 unrelated adult patients with asthma, but in none of 41 subje